Home Dermatology PDF: Risankizumab in Adults with Psoriatic Arthritis
- You cannot add another "PDF: Update on Drugs & Devices: September – October 2019" to your cart. View cart
PDF: Risankizumab in Adults with Psoriatic Arthritis
$1.99
PDF Download: Explore risankizumab for Psoriatic arthritis: Beyond ACR, it significantly improves enthesitis, dactylitis, and QoL scores like HAQ-DI. Promising in efficacy and safety, with full 208-week study results anticipated for a complete understanding.
Read online:
Risankizumab in Adults with Psoriatic Arthritis